1. Home
  2. MIST vs LFVN Comparison

MIST vs LFVN Comparison

Compare MIST & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • LFVN
  • Stock Information
  • Founded
  • MIST 2003
  • LFVN N/A
  • Country
  • MIST Canada
  • LFVN United States
  • Employees
  • MIST N/A
  • LFVN N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • LFVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIST Health Care
  • LFVN Health Care
  • Exchange
  • MIST Nasdaq
  • LFVN Nasdaq
  • Market Cap
  • MIST 81.5M
  • LFVN 127.0M
  • IPO Year
  • MIST N/A
  • LFVN N/A
  • Fundamental
  • Price
  • MIST $1.43
  • LFVN $12.18
  • Analyst Decision
  • MIST Strong Buy
  • LFVN
  • Analyst Count
  • MIST 3
  • LFVN 0
  • Target Price
  • MIST $13.00
  • LFVN N/A
  • AVG Volume (30 Days)
  • MIST 177.8K
  • LFVN 94.6K
  • Earning Date
  • MIST 11-11-2024
  • LFVN 10-29-2024
  • Dividend Yield
  • MIST N/A
  • LFVN 1.23%
  • EPS Growth
  • MIST N/A
  • LFVN 15.00
  • EPS
  • MIST N/A
  • LFVN 0.23
  • Revenue
  • MIST N/A
  • LFVN $200,164,000.00
  • Revenue This Year
  • MIST N/A
  • LFVN $4.36
  • Revenue Next Year
  • MIST N/A
  • LFVN $3.85
  • P/E Ratio
  • MIST N/A
  • LFVN $56.43
  • Revenue Growth
  • MIST N/A
  • LFVN N/A
  • 52 Week Low
  • MIST $1.12
  • LFVN $4.20
  • 52 Week High
  • MIST $3.52
  • LFVN $14.71
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • LFVN 51.31
  • Support Level
  • MIST $1.41
  • LFVN $11.68
  • Resistance Level
  • MIST $1.53
  • LFVN $14.71
  • Average True Range (ATR)
  • MIST 0.07
  • LFVN 0.79
  • MACD
  • MIST -0.01
  • LFVN -0.05
  • Stochastic Oscillator
  • MIST 26.96
  • LFVN 19.04

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: